Free Trial

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 15.85 +0.08 (+0.48%)
As of 07/4/2025

BVC vs. TSTL, SPEC, AKR, CNSL, ODX, CTEC, AMS, HZD, FARN, and MGP

Should you be buying BATM Advanced Communications stock or one of its competitors? The main competitors of BATM Advanced Communications include Tristel (TSTL), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Horizon Discovery Group plc (HZD.L) (HZD), Faron Pharmaceuticals Oy (FARN), and Medica Group (MGP). These companies are all part of the "medical" sector.

BATM Advanced Communications vs. Its Competitors

Tristel (LON:TSTL) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and institutional ownership.

Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.1%. BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 6.3%. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. BATM Advanced Communications pays out -2,321.5% of its earnings in the form of a dividend. BATM Advanced Communications is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Tristel and Tristel both had 2 articles in the media. BATM Advanced Communications' average media sentiment score of 1.23 beat Tristel's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tristel
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BATM Advanced Communications
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tristel has higher earnings, but lower revenue than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tristel£42.24M4.70£6.54M£13.6630.44
BATM Advanced Communications£130.32M0.65-£278.26K-£0.04-367.96

50.4% of Tristel shares are owned by institutional investors. Comparatively, 42.4% of BATM Advanced Communications shares are owned by institutional investors. 4.9% of Tristel shares are owned by company insiders. Comparatively, 26.2% of BATM Advanced Communications shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Tristel has a net margin of 15.47% compared to BATM Advanced Communications' net margin of -0.21%. Tristel's return on equity of 20.43% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
Tristel15.47% 20.43% 9.89%
BATM Advanced Communications -0.21%-0.22%0.58%

Tristel has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. Comparatively, BATM Advanced Communications has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500.

Summary

Tristel beats BATM Advanced Communications on 8 of the 14 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£84.17M£3.81B£5.55B£2.96B
Dividend Yield3.52%1.99%5.22%5.02%
P/E Ratio-367.9618.9327.66147.88
Price / Sales0.65430.86419.21258,917.23
Price / Cash2.12146.5436.8927.97
Price / Book0.682.788.034.61
Net Income-£278.26K£99.80M£3.18B£5.90B
7 Day Performance-0.23%-0.45%2.93%1.04%
1 Month Performance-11.70%-0.52%1.72%4.36%
1 Year Performance-14.32%124.76%34.39%82.36%

BATM Advanced Communications Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
N/AGBX 15.85
+0.5%
N/A-14.3%£84.17M£130.32M-367.96980News Coverage
Positive News
TSTL
Tristel
N/AGBX 400
flat
N/A-10.0%£191.08M£42.24M29.27208Gap Down
High Trading Volume
SPEC
INSPECS Group
N/AGBX 50
+2.0%
N/A-9.2%£50.84M£195.14M-12.381,673Gap Up
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 3.91
+4.3%
N/A+7.5%£9.30M£9.77M-362.103,200Gap Up
High Trading Volume
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
2.1753 of 5 stars
GBX 257.09
-5.5%
GBX 301.67
+17.3%
+10.5%£6.54B£2.71B43.3010,000News Coverage
Analyst Forecast
AMS
Advanced Medical Solutions Group
3.0744 of 5 stars
GBX 204
-2.9%
GBX 300
+47.1%
-8.4%£440.49M£132.18M39.5310News Coverage
Positive News
HZD
Horizon Discovery Group plc (HZD.L)
N/AN/AN/AN/A£302.98M£54.63M-33.55416
FARN
Faron Pharmaceuticals Oy
N/AGBX 219
+8.1%
N/A+125.8%£294.01MN/A-5.8634Positive News
Gap Up
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212

Related Companies and Tools


This page (LON:BVC) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners